nodes	percent_of_prediction	percent_of_DWPC	metapath
Diflunisal—PTGS2—amyotrophic lateral sclerosis	0.77	1	CbGaD
Diflunisal—UGT1A8—tongue—amyotrophic lateral sclerosis	0.021	0.243	CbGeAlD
Diflunisal—TTR—peripheral nervous system—amyotrophic lateral sclerosis	0.0126	0.146	CbGeAlD
Diflunisal—TTR—hindbrain—amyotrophic lateral sclerosis	0.00738	0.0855	CbGeAlD
Diflunisal—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00564	0.0652	CbGeAlD
Diflunisal—PTGS2—appendage—amyotrophic lateral sclerosis	0.00483	0.056	CbGeAlD
Diflunisal—TTR—embryo—amyotrophic lateral sclerosis	0.00462	0.0535	CbGeAlD
Diflunisal—TTR—brainstem—amyotrophic lateral sclerosis	0.00423	0.049	CbGeAlD
Diflunisal—Photosensitivity—Riluzole—amyotrophic lateral sclerosis	0.00396	0.0383	CcSEcCtD
Diflunisal—Deafness—Riluzole—amyotrophic lateral sclerosis	0.00388	0.0375	CcSEcCtD
Diflunisal—Dermatitis exfoliative—Riluzole—amyotrophic lateral sclerosis	0.00368	0.0356	CcSEcCtD
Diflunisal—Gastrointestinal haemorrhage—Riluzole—amyotrophic lateral sclerosis	0.00347	0.0336	CcSEcCtD
Diflunisal—Gastritis—Riluzole—amyotrophic lateral sclerosis	0.00308	0.0297	CcSEcCtD
Diflunisal—TTR—medulla oblongata—amyotrophic lateral sclerosis	0.00295	0.0342	CbGeAlD
Diflunisal—Dysuria—Riluzole—amyotrophic lateral sclerosis	0.00281	0.0271	CcSEcCtD
Diflunisal—Photosensitivity reaction—Riluzole—amyotrophic lateral sclerosis	0.00274	0.0265	CcSEcCtD
Diflunisal—TTR—spinal cord—amyotrophic lateral sclerosis	0.00263	0.0305	CbGeAlD
Diflunisal—Jaundice—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0252	CcSEcCtD
Diflunisal—Stomatitis—Riluzole—amyotrophic lateral sclerosis	0.00261	0.0252	CcSEcCtD
Diflunisal—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00257	0.0248	CcSEcCtD
Diflunisal—Haematuria—Riluzole—amyotrophic lateral sclerosis	0.00255	0.0247	CcSEcCtD
Diflunisal—Agranulocytosis—Riluzole—amyotrophic lateral sclerosis	0.0025	0.0242	CcSEcCtD
Diflunisal—TTR—Retinoid metabolism and transport—PLB1—amyotrophic lateral sclerosis	0.00247	0.0718	CbGpPWpGaD
Diflunisal—Hepatitis—Riluzole—amyotrophic lateral sclerosis	0.0024	0.0232	CcSEcCtD
Diflunisal—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.00239	0.0231	CcSEcCtD
Diflunisal—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00227	0.022	CcSEcCtD
Diflunisal—TTR—nervous system—amyotrophic lateral sclerosis	0.00222	0.0257	CbGeAlD
Diflunisal—TTR—central nervous system—amyotrophic lateral sclerosis	0.00213	0.0247	CbGeAlD
Diflunisal—TTR—cerebellum—amyotrophic lateral sclerosis	0.00209	0.0242	CbGeAlD
Diflunisal—Flatulence—Riluzole—amyotrophic lateral sclerosis	0.00206	0.0199	CcSEcCtD
Diflunisal—Tension—Riluzole—amyotrophic lateral sclerosis	0.00205	0.0198	CcSEcCtD
Diflunisal—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00203	0.0196	CcSEcCtD
Diflunisal—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.00201	0.0194	CcSEcCtD
Diflunisal—Angioedema—Riluzole—amyotrophic lateral sclerosis	0.00191	0.0185	CcSEcCtD
Diflunisal—Vertigo—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0182	CcSEcCtD
Diflunisal—Syncope—Riluzole—amyotrophic lateral sclerosis	0.00188	0.0181	CcSEcCtD
Diflunisal—Palpitations—Riluzole—amyotrophic lateral sclerosis	0.00185	0.0179	CcSEcCtD
Diflunisal—Loss of consciousness—Riluzole—amyotrophic lateral sclerosis	0.00184	0.0178	CcSEcCtD
Diflunisal—Chest pain—Riluzole—amyotrophic lateral sclerosis	0.00178	0.0172	CcSEcCtD
Diflunisal—SLC22A6—brain—amyotrophic lateral sclerosis	0.00173	0.0201	CbGeAlD
Diflunisal—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0166	CcSEcCtD
Diflunisal—Anaphylactic shock—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0165	CcSEcCtD
Diflunisal—Oedema—Riluzole—amyotrophic lateral sclerosis	0.00171	0.0165	CcSEcCtD
Diflunisal—TTR—brain—amyotrophic lateral sclerosis	0.00169	0.0196	CbGeAlD
Diflunisal—Shock—Riluzole—amyotrophic lateral sclerosis	0.00168	0.0162	CcSEcCtD
Diflunisal—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.00167	0.0162	CcSEcCtD
Diflunisal—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00165	0.016	CcSEcCtD
Diflunisal—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.00163	0.0157	CcSEcCtD
Diflunisal—PTGS2—embryo—amyotrophic lateral sclerosis	0.00161	0.0186	CbGeAlD
Diflunisal—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.00154	0.0149	CcSEcCtD
Diflunisal—Paraesthesia—Riluzole—amyotrophic lateral sclerosis	0.00153	0.0148	CcSEcCtD
Diflunisal—Dyspnoea—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0147	CcSEcCtD
Diflunisal—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.00152	0.0147	CcSEcCtD
Diflunisal—Dyspepsia—Riluzole—amyotrophic lateral sclerosis	0.0015	0.0145	CcSEcCtD
Diflunisal—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.00148	0.0144	CcSEcCtD
Diflunisal—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.00147	0.0142	CcSEcCtD
Diflunisal—Constipation—Riluzole—amyotrophic lateral sclerosis	0.00146	0.0141	CcSEcCtD
Diflunisal—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.00141	0.0136	CcSEcCtD
Diflunisal—Gastrointestinal pain—Riluzole—amyotrophic lateral sclerosis	0.0014	0.0135	CcSEcCtD
Diflunisal—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.00136	0.0131	CcSEcCtD
Diflunisal—Olsalazine—PTGS2—amyotrophic lateral sclerosis	0.00135	0.222	CrCbGaD
Diflunisal—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.00135	0.013	CcSEcCtD
Diflunisal—Aminosalicylic Acid—PTGS2—amyotrophic lateral sclerosis	0.00127	0.209	CrCbGaD
Diflunisal—TTR—Diseases associated with visual transduction—PLB1—amyotrophic lateral sclerosis	0.00126	0.0366	CbGpPWpGaD
Diflunisal—Hypersensitivity—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0122	CcSEcCtD
Diflunisal—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.00123	0.0118	CcSEcCtD
Diflunisal—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0117	CcSEcCtD
Diflunisal—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.00117	0.0113	CcSEcCtD
Diflunisal—Salsalate—PTGS2—amyotrophic lateral sclerosis	0.00115	0.189	CrCbGaD
Diflunisal—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0109	CcSEcCtD
Diflunisal—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0105	CcSEcCtD
Diflunisal—ALB—brain—amyotrophic lateral sclerosis	0.00108	0.0125	CbGeAlD
Diflunisal—Rash—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0104	CcSEcCtD
Diflunisal—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00108	0.0104	CcSEcCtD
Diflunisal—Headache—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0103	CcSEcCtD
Diflunisal—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.00103	0.0119	CbGeAlD
Diflunisal—Nausea—Riluzole—amyotrophic lateral sclerosis	0.00101	0.00981	CcSEcCtD
Diflunisal—Mesalazine—PTGS2—amyotrophic lateral sclerosis	0.000997	0.164	CrCbGaD
Diflunisal—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000957	0.0111	CbGeAlD
Diflunisal—TTR—Amyloids—CST3—amyotrophic lateral sclerosis	0.000927	0.0269	CbGpPWpGaD
Diflunisal—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000915	0.0106	CbGeAlD
Diflunisal—PTGS1—nervous system—amyotrophic lateral sclerosis	0.000806	0.00934	CbGeAlD
Diflunisal—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000776	0.00899	CbGeAlD
Diflunisal—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000771	0.00892	CbGeAlD
Diflunisal—UGT1A8—Phase II conjugation—GSTP1—amyotrophic lateral sclerosis	0.000768	0.0223	CbGpPWpGaD
Diflunisal—TTR—Retinoid metabolism and transport—APOE—amyotrophic lateral sclerosis	0.000762	0.0221	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—PTPRZ1—amyotrophic lateral sclerosis	0.000751	0.0218	CbGpPWpGaD
Diflunisal—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000742	0.00859	CbGeAlD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—RAB5A—amyotrophic lateral sclerosis	0.000735	0.0213	CbGpPWpGaD
Diflunisal—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—TPK1—amyotrophic lateral sclerosis	0.000727	0.0211	CbGpPWpGaD
Diflunisal—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000725	0.0084	CbGeAlD
Diflunisal—Salicylic acid—PTGS2—amyotrophic lateral sclerosis	0.000707	0.116	CrCbGaD
Diflunisal—Flurbiprofen—PTGS2—amyotrophic lateral sclerosis	0.000619	0.102	CrCbGaD
Diflunisal—PTGS1—brain—amyotrophic lateral sclerosis	0.000616	0.00714	CbGeAlD
Diflunisal—PTGS2—brain—amyotrophic lateral sclerosis	0.000589	0.00682	CbGeAlD
Diflunisal—PTGS1—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000459	0.0133	CbGpPWpGaD
Diflunisal—PTGS1—Synthesis of Prostaglandins (PG) and Thromboxanes (TX)—PTGS2—amyotrophic lateral sclerosis	0.000456	0.0132	CbGpPWpGaD
Diflunisal—UGT1A8—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000449	0.013	CbGpPWpGaD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.00044	0.0128	CbGpPWpGaD
Diflunisal—ALB—HDL-mediated lipid transport—APOE—amyotrophic lateral sclerosis	0.000405	0.0117	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—amyotrophic lateral sclerosis	0.000403	0.0117	CbGpPWpGaD
Diflunisal—TTR—Diseases associated with visual transduction—APOE—amyotrophic lateral sclerosis	0.000389	0.0113	CbGpPWpGaD
Diflunisal—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC6A1—amyotrophic lateral sclerosis	0.000384	0.0111	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000364	0.0106	CbGpPWpGaD
Diflunisal—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—amyotrophic lateral sclerosis	0.000359	0.0104	CbGpPWpGaD
Diflunisal—PTGS1—Overview of nanoparticle effects—PTGS2—amyotrophic lateral sclerosis	0.000357	0.0104	CbGpPWpGaD
Diflunisal—PTGS2—Prostaglandin Synthesis and Regulation—PLA2G4A—amyotrophic lateral sclerosis	0.000349	0.0101	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000344	0.00998	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000344	0.00998	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—TUBA4A—amyotrophic lateral sclerosis	0.00033	0.00958	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000315	0.00913	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—TUBA4A—amyotrophic lateral sclerosis	0.000315	0.00913	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—PLA2G4A—amyotrophic lateral sclerosis	0.000309	0.00896	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—PFN1—amyotrophic lateral sclerosis	0.000297	0.00863	CbGpPWpGaD
Diflunisal—PTGS1—Eicosanoid Synthesis—PTGS2—amyotrophic lateral sclerosis	0.000297	0.0086	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—GSR—amyotrophic lateral sclerosis	0.000295	0.00854	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—RTN4—amyotrophic lateral sclerosis	0.000293	0.00851	CbGpPWpGaD
Diflunisal—TTR—Disease—TPK1—amyotrophic lateral sclerosis	0.000293	0.00849	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000293	0.00849	CbGpPWpGaD
Diflunisal—PTGS1—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000292	0.00848	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—PFN1—amyotrophic lateral sclerosis	0.000283	0.00822	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000275	0.00798	CbGpPWpGaD
Diflunisal—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—amyotrophic lateral sclerosis	0.000256	0.00744	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.00025	0.00724	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—DAO—amyotrophic lateral sclerosis	0.000249	0.00722	CbGpPWpGaD
Diflunisal—PTGS1—Prostaglandin Synthesis and Regulation—PTGS2—amyotrophic lateral sclerosis	0.000248	0.0072	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—GFAP—amyotrophic lateral sclerosis	0.000239	0.00694	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—AQP4—amyotrophic lateral sclerosis	0.000236	0.00686	CbGpPWpGaD
Diflunisal—TTR—Disease—VTA1—amyotrophic lateral sclerosis	0.000234	0.00679	CbGpPWpGaD
Diflunisal—ALB—Lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000232	0.00674	CbGpPWpGaD
Diflunisal—PTGS2—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000232	0.00673	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—amyotrophic lateral sclerosis	0.000232	0.00673	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00023	0.00667	CbGpPWpGaD
Diflunisal—PTGS2—S1P1 pathway—VEGFA—amyotrophic lateral sclerosis	0.000224	0.00648	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000207	0.00602	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—SOD1—amyotrophic lateral sclerosis	0.000206	0.00598	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000204	0.00591	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	0.000203	0.0059	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000196	0.00567	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000189	0.00547	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000186	0.00541	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000181	0.00526	CbGpPWpGaD
Diflunisal—ALB—Binding and Uptake of Ligands by Scavenger Receptors—APOE—amyotrophic lateral sclerosis	0.000181	0.00525	CbGpPWpGaD
Diflunisal—TTR—Disease—CHMP2B—amyotrophic lateral sclerosis	0.000177	0.00515	CbGpPWpGaD
Diflunisal—SLC22A6—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000174	0.00506	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GSR—amyotrophic lateral sclerosis	0.000174	0.00505	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000173	0.00503	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—SOD1—amyotrophic lateral sclerosis	0.000168	0.00486	CbGpPWpGaD
Diflunisal—PTGS1—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	0.000165	0.00478	CbGpPWpGaD
Diflunisal—PTGS2—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000165	0.00478	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000163	0.00473	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000162	0.00469	CbGpPWpGaD
Diflunisal—TTR—Disease—PLB1—amyotrophic lateral sclerosis	0.00016	0.00465	CbGpPWpGaD
Diflunisal—ALB—Lipid and lipoprotein metabolism—APOE—amyotrophic lateral sclerosis	0.000155	0.00448	CbGpPWpGaD
Diflunisal—ALB—Vitamin B12 Metabolism—APOE—amyotrophic lateral sclerosis	0.000152	0.00441	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.000148	0.00429	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—TUBA4A—amyotrophic lateral sclerosis	0.000146	0.00425	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—SOD1—amyotrophic lateral sclerosis	0.000144	0.00417	CbGpPWpGaD
Diflunisal—TTR—Disease—VCP—amyotrophic lateral sclerosis	0.000143	0.00415	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000143	0.00414	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	0.00014	0.00406	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000138	0.00399	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—amyotrophic lateral sclerosis	0.000137	0.00397	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	0.000136	0.00394	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—SOD1—amyotrophic lateral sclerosis	0.000133	0.00386	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PFN1—amyotrophic lateral sclerosis	0.000132	0.00383	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.000131	0.0038	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000129	0.00375	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	0.000128	0.00371	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—BDNF—amyotrophic lateral sclerosis	0.000122	0.00355	CbGpPWpGaD
Diflunisal—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CASP3—amyotrophic lateral sclerosis	0.000121	0.00352	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00012	0.00347	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.00012	0.00347	CbGpPWpGaD
Diflunisal—PTGS1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.000118	0.00344	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000117	0.00339	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.000112	0.00326	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.000112	0.00324	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.000111	0.00323	CbGpPWpGaD
Diflunisal—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—amyotrophic lateral sclerosis	0.00011	0.0032	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—CASP3—amyotrophic lateral sclerosis	0.000109	0.00317	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—KIFAP3—amyotrophic lateral sclerosis	0.000109	0.00316	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.000106	0.00306	CbGpPWpGaD
Diflunisal—PTGS1—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	0.000105	0.00304	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.000105	0.00303	CbGpPWpGaD
Diflunisal—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	0.000104	0.00301	CbGpPWpGaD
Diflunisal—TTR—Extracellular matrix organization—MMP9—amyotrophic lateral sclerosis	0.000103	0.00299	CbGpPWpGaD
Diflunisal—TTR—Disease—CST3—amyotrophic lateral sclerosis	0.000103	0.00298	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000102	0.00295	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.0001	0.0029	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	9.94e-05	0.00288	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	9.94e-05	0.00288	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	9.87e-05	0.00286	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	9.7e-05	0.00281	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	9.43e-05	0.00274	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	9.07e-05	0.00263	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	9.07e-05	0.00263	CbGpPWpGaD
Diflunisal—ALB—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	9.06e-05	0.00263	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	8.86e-05	0.00257	CbGpPWpGaD
Diflunisal—SLC22A6—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	8.86e-05	0.00257	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—IGF1—amyotrophic lateral sclerosis	8.77e-05	0.00254	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	8.61e-05	0.0025	CbGpPWpGaD
Diflunisal—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	8.6e-05	0.0025	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	8.51e-05	0.00247	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	8.46e-05	0.00245	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—amyotrophic lateral sclerosis	8.35e-05	0.00242	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	8.32e-05	0.00241	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	8.3e-05	0.00241	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	7.94e-05	0.0023	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.72e-05	0.00224	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.68e-05	0.00223	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TUBA4A—amyotrophic lateral sclerosis	7.55e-05	0.00219	CbGpPWpGaD
Diflunisal—TTR—Disease—CASP9—amyotrophic lateral sclerosis	7.46e-05	0.00216	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	7.25e-05	0.0021	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	7.2e-05	0.00209	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	7.2e-05	0.00209	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	7.17e-05	0.00208	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.06e-05	0.00205	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—RAB5A—amyotrophic lateral sclerosis	7.02e-05	0.00204	CbGpPWpGaD
Diflunisal—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	6.88e-05	0.00199	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PFN1—amyotrophic lateral sclerosis	6.8e-05	0.00197	CbGpPWpGaD
Diflunisal—ALB—Selenium Micronutrient Network—PTGS2—amyotrophic lateral sclerosis	6.74e-05	0.00195	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	6.72e-05	0.00195	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	6.59e-05	0.00191	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	6.56e-05	0.0019	CbGpPWpGaD
Diflunisal—TTR—Disease—ERBB4—amyotrophic lateral sclerosis	6.39e-05	0.00185	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—SOD1—amyotrophic lateral sclerosis	6.38e-05	0.00185	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	6.12e-05	0.00178	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	6.11e-05	0.00177	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.08e-05	0.00176	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	5.85e-05	0.0017	CbGpPWpGaD
Diflunisal—ALB—Metabolism—VAPB—amyotrophic lateral sclerosis	5.83e-05	0.00169	CbGpPWpGaD
Diflunisal—ALB—Metabolism—TPK1—amyotrophic lateral sclerosis	5.83e-05	0.00169	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—APOE—amyotrophic lateral sclerosis	5.81e-05	0.00168	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	5.78e-05	0.00168	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	5.76e-05	0.00167	CbGpPWpGaD
Diflunisal—ALB—Platelet degranulation—VEGFA—amyotrophic lateral sclerosis	5.73e-05	0.00166	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—PLA2G4A—amyotrophic lateral sclerosis	5.72e-05	0.00166	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	5.49e-05	0.00159	CbGpPWpGaD
Diflunisal—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—amyotrophic lateral sclerosis	5.45e-05	0.00158	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	5.43e-05	0.00158	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	5.4e-05	0.00157	CbGpPWpGaD
Diflunisal—ALB—Metabolism—VAPA—amyotrophic lateral sclerosis	5.33e-05	0.00155	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	5.22e-05	0.00152	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	5.21e-05	0.00151	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	5.21e-05	0.00151	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.17e-05	0.0015	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.17e-05	0.0015	CbGpPWpGaD
Diflunisal—ALB—Folate Metabolism—TP53—amyotrophic lateral sclerosis	5.05e-05	0.00146	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	4.97e-05	0.00144	CbGpPWpGaD
Diflunisal—ALB—Metabolism—SACM1L—amyotrophic lateral sclerosis	4.96e-05	0.00144	CbGpPWpGaD
Diflunisal—TTR—Disease—APOE—amyotrophic lateral sclerosis	4.94e-05	0.00143	CbGpPWpGaD
Diflunisal—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	4.71e-05	0.00137	CbGpPWpGaD
Diflunisal—ALB—Metabolism—FIG4—amyotrophic lateral sclerosis	4.66e-05	0.00135	CbGpPWpGaD
Diflunisal—ALB—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	4.61e-05	0.00134	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	4.59e-05	0.00133	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	4.47e-05	0.0013	CbGpPWpGaD
Diflunisal—ALB—Metabolism—DAO—amyotrophic lateral sclerosis	4.21e-05	0.00122	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	4.2e-05	0.00122	CbGpPWpGaD
Diflunisal—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	4.2e-05	0.00122	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.18e-05	0.00121	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	4.16e-05	0.00121	CbGpPWpGaD
Diflunisal—UGT1A8—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.98e-05	0.00115	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	3.95e-05	0.00114	CbGpPWpGaD
Diflunisal—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	3.92e-05	0.00114	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—IGF1—amyotrophic lateral sclerosis	3.89e-05	0.00113	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	3.77e-05	0.00109	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—C3—amyotrophic lateral sclerosis	3.72e-05	0.00108	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	3.64e-05	0.00106	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3.53e-05	0.00102	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—APOE—amyotrophic lateral sclerosis	3.46e-05	0.001	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.44e-05	0.000997	CbGpPWpGaD
Diflunisal—TTR—Disease—PTGS2—amyotrophic lateral sclerosis	3.38e-05	0.000982	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	3.32e-05	0.000962	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—SOD1—amyotrophic lateral sclerosis	3.29e-05	0.000953	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PLB1—amyotrophic lateral sclerosis	3.19e-05	0.000926	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	3.01e-05	0.000875	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	2.99e-05	0.000868	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—PLA2G4A—amyotrophic lateral sclerosis	2.95e-05	0.000855	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSR—amyotrophic lateral sclerosis	2.95e-05	0.000855	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	2.86e-05	0.000829	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.73e-05	0.000792	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.68e-05	0.000779	CbGpPWpGaD
Diflunisal—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.67e-05	0.000773	CbGpPWpGaD
Diflunisal—ALB—Platelet activation, signaling and aggregation—VEGFA—amyotrophic lateral sclerosis	2.54e-05	0.000737	CbGpPWpGaD
Diflunisal—ALB—Metabolism—CHAT—amyotrophic lateral sclerosis	2.42e-05	0.000702	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.36e-05	0.000683	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.21e-05	0.000641	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	2.2e-05	0.000638	CbGpPWpGaD
Diflunisal—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	2.19e-05	0.000636	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	2.08e-05	0.000603	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.03e-05	0.000587	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—IGF1—amyotrophic lateral sclerosis	2e-05	0.000581	CbGpPWpGaD
Diflunisal—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	1.88e-05	0.000544	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	1.87e-05	0.000542	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.86e-05	0.00054	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.61e-05	0.000466	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	1.53e-05	0.000444	CbGpPWpGaD
Diflunisal—ALB—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.51e-05	0.000439	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.48e-05	0.000429	CbGpPWpGaD
Diflunisal—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	1.45e-05	0.000421	CbGpPWpGaD
Diflunisal—TTR—Signaling Pathways—TP53—amyotrophic lateral sclerosis	1.41e-05	0.000409	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—VEGFA—amyotrophic lateral sclerosis	1.31e-05	0.00038	CbGpPWpGaD
Diflunisal—ALB—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.3e-05	0.000377	CbGpPWpGaD
Diflunisal—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	1.22e-05	0.000353	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.2e-05	0.000347	CbGpPWpGaD
Diflunisal—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.05e-05	0.000304	CbGpPWpGaD
Diflunisal—ALB—Hemostasis—TP53—amyotrophic lateral sclerosis	9.89e-06	0.000287	CbGpPWpGaD
Diflunisal—ALB—Metabolism—APOE—amyotrophic lateral sclerosis	9.83e-06	0.000285	CbGpPWpGaD
Diflunisal—ALB—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.74e-06	0.000195	CbGpPWpGaD
